Back
Spyre Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
SYRE
Sponsored
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Sell
42
SYRE
Spyre Therapeutics
Last Price:
32.98
Seasonality Move:
2.92%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.Spyre Therapeutics Price Quote
$32.98
-0.04 (-3.71%)
(Updated: May 9, 2024 at 6:28 AM ET)
Spyre Therapeutics Key Stats
Sell
42
Spyre Therapeutics (SYRE)
is a Sell
Day range:
$31.79 - $34.34
52-week range:
$2.66 - $47.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
322.29
P/B ratio:
0%
Volume:
245.1K
Avg. volume:
351.5K
1-year change:
735.95%
Market cap:
$1.2B
Revenue:
$886K
EPS:
$-72.84
How Much Does Spyre Therapeutics Make?
Data Unavailable
Is Spyre Therapeutics Growing As A Company?
Data Unavailable
Spyre Therapeutics Stock Price Performance
-
Did Spyre Therapeutics Stock Go Up Last Month?
Spyre Therapeutics share price went down by -11.07% last month -
Did SYRE's Share Price Rise Over The Last Year?
SYRE share price rose by 735.95% over the past 1 year
What Is Spyre Therapeutics 52-Week High & Low?
-
What Is Spyre Therapeutics’s 52-Week High Share Price?
Spyre Therapeutics has traded as high as $47.97 over the past 52 weeks -
What Is Spyre Therapeutics’s 52-Week Low Share Price?
Spyre Therapeutics has traded as low as $2.66 over the past 52 weeks
Spyre Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Spyre Therapeutics?
-
How Much Debt Does Spyre Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Spyre Therapeutics Have?
Cash and short term investments quarterly total is $339.3M -
What Is Spyre Therapeutics’s Book Value Per Share?
Book value per share is -0.03
Is Spyre Therapeutics Cash Flow Positive?
-
What Is SYRE Cash Flow From Operations?
Cash flow from operations (TTM) is -$99.9M -
What Is Spyre Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $361.1M -
What Is Spyre Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$108.4M
Spyre Therapeutics Return On Invested Capital
Data Unavailable
Spyre Therapeutics Earnings Date & Stock Price
-
What Is Spyre Therapeutics's Stock Price Today?
A single share of SYRE can be purchased today for 33.02 -
What Is Spyre Therapeutics’s Stock Symbol?
Spyre Therapeutics trades on the nasdaq under the ticker symbol: SYRE -
When Is Spyre Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Spyre Therapeutics is scheduled on May 10, 2024 -
When Is SYRE's next ex-dividend date?
Spyre Therapeutics's next ex-dividend date is May 9, 2024 -
How To Buy Spyre Therapeutics Stock?
You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Spyre Therapeutics Competitors
-
Who Are Spyre Therapeutics's Competitors?
Below is a list of companies who compete with Spyre Therapeutics or are related in some way:
Spyre Therapeutics Dividend Yield
Data Unavailable
Spyre Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -389.13% |
Revenue: | 0% | -100% |
Analyst Recommendations
Buy Recommendations: | 8 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 43.14 |
Upside from Last Price: | 30.66% |